Seeking Alpha

NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for ...

MALVERN, Pa., March 25, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for ...
Seeking Alpha

NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness Month

MALVERN, Pa., May 01, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life ...
Nasdaq

NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for ...

MALVERN, Pa., March 25, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of ...
Monthly Prescribing Reference

TMS Device NeuroStar Cleared as Add-On Treatment for Adolescent Depression

NeuroStar Advanced Therapy is a transcranial magnetic stimulation system that uses magnetic fields to induce neural activity in the cerebral cortex. The Food and Drug Administration (FDA) has cleared ...
Nasdaq

NeuroStar Advanced Therapy for Mental Health Announces Partnership with Mental Health ...

MALVERN, Pa., May 03, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the ...
Business Insider

NeuroStar Elevates Depression Treatment with Cutting-Edge Technology Advancements

MALVERN, Pa., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life ...